These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 37724766)
1. Treating refractory acne conglobata with secukinumab: A case report. Jiang W; Wang X; Li N; Chen J; Li C J Dermatol; 2024 Feb; 51(2):e51-e52. PubMed ID: 37724766 [No Abstract] [Full Text] [Related]
2. Adalimumab for the treatment of refractory acne conglobata. Sand FL; Thomsen SF JAMA Dermatol; 2013 Nov; 149(11):1306-7. PubMed ID: 24048280 [No Abstract] [Full Text] [Related]
3. Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata. Liu S; Wu X; Cao Y; Li Z; Liu Y; Ma M; Li C Pediatr Rheumatol Online J; 2022 Oct; 20(1):88. PubMed ID: 36224598 [TBL] [Abstract][Full Text] [Related]
4. A case of 5-aminolevulinic acid photodynamic therapy(ALA-PDT)combined with surgery for the treatment of acne conglobata. Wu QY; Zhang Q; Bu WB; Fang F Photodiagnosis Photodyn Ther; 2022 Sep; 39():102986. PubMed ID: 35760351 [TBL] [Abstract][Full Text] [Related]
6. Laser treatment of acne conglobatа with concomitant oral isotretinoin use. Kalashnikova NG; Albanova VI; Jafferany M Dermatol Ther; 2021 Jan; 34(1):e14553. PubMed ID: 33205848 [No Abstract] [Full Text] [Related]
7. Remission of Refractory PASH Syndrome Using Ixekizumab and Doxycycline. Gul MI; Singam V; Hanson C; Neill BC; Aires DJ; Rajpara AN J Drugs Dermatol; 2020 Nov; 19(11):1123. PubMed ID: 33196740 [No Abstract] [Full Text] [Related]
8. Treatment of acne conglobata with infliximab. Shirakawa M; Uramoto K; Harada FA J Am Acad Dermatol; 2006 Aug; 55(2):344-6. PubMed ID: 16844527 [TBL] [Abstract][Full Text] [Related]
9. Acne conglobata and adalimumab: use of tumour necrosis factor-α antagonists in treatment-resistant acne conglobata, and review of the literature. Yiu ZZ; Madan V; Griffiths CE Clin Exp Dermatol; 2015 Jun; 40(4):383-6. PubMed ID: 25545016 [TBL] [Abstract][Full Text] [Related]
10. Resident Rounds. Part III A. Serendipitous improvement in moderate to severe acne in psoriasis patients treated with ustekinumab: a two-case series. Jensen JD; Huynh T; Cafardi J; Sami N J Drugs Dermatol; 2013 Jun; 12(6):710-1. PubMed ID: 23839194 [No Abstract] [Full Text] [Related]
11. Off-label Use of Secukinumab: A Potential Therapeutic Option for SAPHO Syndrome. Wang G; Zhuo N; Li J J Rheumatol; 2022 Jun; 49(6):656. PubMed ID: 34911808 [No Abstract] [Full Text] [Related]
12. [13-cis-retinoic acid--an effective therapy for acne conglobata]. Schmidt JB; Fanta D Z Hautkr; 1984 Mar; 59(5):279-87. PubMed ID: 6232766 [TBL] [Abstract][Full Text] [Related]
14. Secukinumab for PASS syndrome: A new choice for therapeutic challenge? Li M; Xiang H; Liang Y; Xue L; Zhou X; Yang L; Liu H; Yang M; Tang J; Li W Dermatol Ther; 2022 Jul; 35(7):e15507. PubMed ID: 35419914 [TBL] [Abstract][Full Text] [Related]
15. Treatment of acne conglobata with modern external beam radiation. Myers JN; Mason AR; Gillespie LK; Salkey KS J Am Acad Dermatol; 2010 May; 62(5):861-3. PubMed ID: 19665259 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of nodulo-cystic acne and acne conglobata with 13-cis-retinoic acid (isotretinoin)]. Cavicchini S; Caputo R G Ital Dermatol Venereol; 1986; 121(3):XXXIII-XXXVII. PubMed ID: 2943670 [No Abstract] [Full Text] [Related]
17. Disfiguring ulcerative neutrophilic dermatosis secondary to doxycycline and isotretinoin in an adolescent boy with acne conglobata. Sotoodian B; Kuzel P; Brassard A; Fiorillo L Cutis; 2017 Dec; 100(6):E23-E26. PubMed ID: 29360905 [TBL] [Abstract][Full Text] [Related]
18. Tildrakizumab in the treatment of PASH syndrome: A potential novel therapeutic target. Kok Y; Nicolopoulos J; Varigos G; Howard A; Dolianitis C Australas J Dermatol; 2020 Aug; 61(3):e373-e374. PubMed ID: 32285437 [No Abstract] [Full Text] [Related]